Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Angiotensin II receptor | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.0273 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0273 | 1 | 1 |
Leishmania major | methionine aminopeptidase 2, putative | 0.0273 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.0273 | 1 | 1 |
Mycobacterium tuberculosis | Dipeptidase PepE | 0.0034 | 0 | 0.5 |
Onchocerca volvulus | Methionine aminopeptidase 2 homolog | 0.0273 | 1 | 1 |
Mycobacterium ulcerans | dipeptidase PepE | 0.0034 | 0 | 0.5 |
Mycobacterium leprae | Probable cytoplasmic peptidase PepQ | 0.0034 | 0 | 0.5 |
Loa Loa (eye worm) | initiation factor 2-associated protein | 0.0273 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytoplasmic peptidase PepQ | 0.0034 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0273 | 1 | 1 |
Mycobacterium ulcerans | aminopeptidase | 0.0034 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0034 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | Xaa-Pro aminopeptidase | 0.0034 | 0 | 0.5 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0034 | 0 | 0.5 |
Treponema pallidum | aminopeptidase P | 0.0034 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase 2, putative | 0.0273 | 1 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 2 | 0.0273 | 1 | 1 |
Chlamydia trachomatis | aminopeptidase P | 0.0034 | 0 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 2 | 0.0273 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0034 | 0 | 0.5 |
Entamoeba histolytica | methionine aminopeptidase, putative | 0.0273 | 1 | 1 |
Trypanosoma brucei | metallo-peptidase, Clan MG, Family M24 | 0.0273 | 1 | 1 |
Giardia lamblia | Methionine aminopeptidase | 0.0273 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0273 | 1 | 1 |
Schistosoma mansoni | methionyl aminopeptidase 2 (M24 family) | 0.0273 | 1 | 1 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0034 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0273 | 1 | 1 |
Mycobacterium ulcerans | cytoplasmic peptidase PepQ | 0.0034 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0034 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0034 | 0 | 0.5 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0034 | 0 | 0.5 |
Mycobacterium ulcerans | dipeptidase | 0.0034 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0034 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0034 | 0 | 0.5 |
Echinococcus granulosus | methionyl aminopeptidase 2 | 0.0273 | 1 | 1 |
Toxoplasma gondii | methionine aminopeptidase 2, putative | 0.0273 | 1 | 1 |
Plasmodium vivax | methionine aminopeptidase 2, putative | 0.0273 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 74 nM | Angiotensin II receptor antagonist activity was determined by 50% inhibition of specific binding of [3H]-angiotensin II (2 nM) to rat adrenal cortical microsomes | ChEMBL. | No reference |
IC50 (binding) | = 74 nM | Angiotensin II receptor antagonist activity was determined by 50% inhibition of specific binding of [3H]-angiotensin II (2 nM) to rat adrenal cortical microsomes | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.